Cell Phone Application to Help Adolescents and Young Adults in Their Therapeutic and Educational Journey

NCT05617131 | Unknown

• 1 other identifier: 7599
• Study Type: observational
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

About 2000 cancers/year in France are diagnosed in Adolescents and Young Adults (15-25 years old, AYA). The cancer plans and the INCA recommend support during and after cancer, taking into account both medical and psychosocial specificities related to age (supportive care, school learning/training and professional integration, fertility preservation, therapeutic education, addictology, sexology...). The care offered is often heterogeneous for these AYAs in transition between the pediatric and adult worlds. They may be cared for either in pediatric oncology units or in adult structures. In this context, an AYA team has been developed in the Strasbourg center, led by a Nurse Coordinator (IDEC), social workers, psychologists and doctors. Thus, the young patients and their relatives are accompanied by professionals during their therapeutic care. In spite of this global care and closer to the patient, it is still necessary to find connected health tools for these AYA.

Conditions

Cancer

Keywords

Solid cancer; Liquid cancer; Connected health tools; OnKO-TnT digital application

Outcome Measures

Primary Outcomes (1)

• Collection of the global score of the MAUQ questionnaire (item 1 to 21), filled in by the patients after 6 months of use of the OnKO-TnT application

  MAUQ questionnaire of 21 items with a score ranging from 1 to 7. Score 7 means a better result

  after 6 months of use of the OnKO-TnT application

Eligibility Criteria

• Age: 15 Years - 25 Years
• Sex: all
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Subject, whose age is ≥ 15 years and ≤ 25 years, diagnosed at the Strasbourg center (HUS and ICANS) with solid or liquid cancer

You may qualify if:

• Subject whose age is ≥ 15 years and ≤ 25 years
• Subject diagnosed at the Strasbourg center (HUS and ICANS) with solid or liquid cancer
• Subject followed in the Strasbourg center (HUS and ICANS)
• Subject (or his/her legal representatives) having given his/her (their) agreement to participate in the evaluation survey of the OnKO-TnT digital application
• Subject agreeing to complete all satisfaction questionnaires
• The subject understands, speaks and writes French fluently
• Subject having a cell phone capable of downloading the application (developed for any type of cell phone)
• Opposition of the subject (or the holders of parental authority) to participate in the satisfaction survey
• Subject under legal protection
• Subject under guardianship or curatorship

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Service Pédiatrie Onco-hématologie - Pédiatrie III - CHU de Strasbourg - France

Strasbourg, 67091, France

RECRUITING

MeSH Terms

Conditions

Neoplasms

Central Study Contacts

Natacha ENTZ-WERLE, MD, PhD

CONTACT

33 3 88 12 83 89; natacha.entz-werle@chru-strasbourg.fr

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 7, 2022
• First Posted: November 15, 2022
• Study Start: January 1, 2020
• Primary Completion: December 1, 2023
• Study Completion: December 31, 2023
• Last Updated: December 19, 2023

Record last verified: 2023-12

Locations

FR (1)